Pramodini Medicare IPO: Date, Price Band, Lot Size, Allotment, GMP and Review
Pramodini Medicare IPO is an upcoming SME IPO that will open for subscription on August 12, 2026, and close on August 14, 2026. The company is looking to raise approximately ₹69.04 crore through the public issue, comprising a fresh issue of approximately ₹63.14 crore and an offer for sale of up to 5,00,400 equity shares.
The Pramodini Medicare IPO price band has been fixed at ₹110 to ₹118 per equity share. The shares are proposed to be listed on the NSE SME platform. The IPO allotment is expected to be finalized on August 17, 2026, while the listing is scheduled for August 19, 2026.
Pramodini Medicare IPO Important Details
| Particular | Details |
|---|---|
| IPO Name | Pramodini Medicare IPO |
| IPO Type | SME IPO |
| IPO Open Date | August 12, 2026 |
| IPO Close Date | August 14, 2026 |
| IPO Allotment Date | August 17, 2026 |
| Refund Date | August 18, 2026 |
| Demat Credit | August 18, 2026 |
| IPO Listing Date | August 19, 2026 |
| IPO Price Band | ₹110 to ₹118 per share |
| Face Value | ₹10 per share |
| Issue Size | Approx. ₹69.04 crore |
| Fresh Issue | Approx. ₹63.14 crore |
| Offer for Sale | Up to 5,00,400 shares |
| Listing | NSE SME |
| Retail Quota | 34.58% |
| QIB Quota | 20.02% excluding anchor |
| NII Quota | 16.41% |
| Lead Manager | Smart Horizon Capital Advisors Pvt. Ltd. |
| Registrar | Purva Sharegistry (India) Pvt. Ltd. |
The IPO reservation structure includes anchor investors, QIBs, NII investors and retail investors. The retail portion accounts for approximately 34.58% of the shares offered, while the NII portion is around 16.41%.
Pramodini Medicare IPO Lot Size
The minimum market lot for the Pramodini Medicare IPO is 2,400 shares. At the upper price band of ₹118 per share, the minimum application amount comes to ₹2,83,200.
| Investor Category | Lots | Shares | Amount |
| Retail Minimum | 2 | 2,400 | ₹2,83,200 |
| Retail Maximum | 2 | 2,400 | ₹2,83,200 |
| S-HNI Minimum | 3 | 3,600 | ₹4,24,800 |
| S-HNI Maximum | 7 | 8,400 | ₹9,91,200 |
| B-HNI Minimum | 8 | 9,600 | ₹11,32,800 |
The relatively high minimum application amount is an important factor for investors considering this SME IPO.
Pramodini Medicare IPO Dates
The Pramodini Medicare IPO will remain open for three trading days.
- IPO Opens: August 12, 2026
- IPO Closes: August 14, 2026
- Basis of Allotment: August 17, 2026
- Refunds: August 18, 2026
- Shares Credited to Demat: August 18, 2026
- IPO Listing: August 19, 2026
Anchor investor bidding is scheduled for August 11, 2026.
About Pramodini Medicare
Pramodini Medicare Limited was established in 2000 and operates in the diagnostic healthcare services sector. The company provides diagnostic services across radiology, clinical laboratory and nuclear medicine.
Its radiology portfolio includes MRI, CT scans, X-ray, ultrasound with colour Doppler, mammography, DEXA scans and interventional radiology. Its clinical laboratory services cover areas such as haematology, microbiology, immunology, pathology and biochemistry.
The company also provides nuclear medicine services, including PET-CT, SPECT and nuclear therapy.
Pramodini Medicare Business Model
Pramodini Medicare operates diagnostic centres through multiple formats, including:
- Public-Private Partnerships (PPP)
- Private-Private Partnerships
- Strategic partnerships with PSUs
- Standalone diagnostic centres
- Location-specific agreements
According to the IPO information, the company has a presence across locations including Vijayawada, Hyderabad, Kurnool, Kadapa, Tirupati, Varanasi and Prayagraj, among others.
Pramodini Medicare IPO Financial Performance
The company’s financial performance has shown growth in both revenue and profit over the reported periods.
| Financial Year | Revenue | Expenses | Profit After Tax |
| FY2024 | ₹35.79 crore | ₹25.72 crore | ₹7.14 crore |
| FY2025 | ₹38.55 crore | ₹22.80 crore | ₹11.14 crore |
| FY2026 | ₹63.38 crore | ₹40.08 crore | ₹17.38 crore |
Revenue increased from ₹38.55 crore in FY2025 to ₹63.38 crore in FY2026, while profit after tax rose from ₹11.14 crore to ₹17.38 crore during the same period.
This represents a significant improvement in the company’s reported top line and bottom line ahead of the IPO.
Pramodini Medicare IPO Valuation
Based on FY2026 figures, the company reported the following key financial indicators:
| Particular | FY2026 |
| ROE | 39.08% |
| ROCE | 34.66% |
| EBITDA Margin | 49.61% |
| PAT Margin | 27.90% |
| Debt-to-Equity | 0.34 |
| Basic EPS | ₹10.41 |
| RoNW | 32.69% |
| NAV | ₹31.84 |
The IPO page reports an FY2026 basic EPS of ₹10.41 and NAV of ₹31.84 per share.
Use of Pramodini Medicare IPO Proceeds
The company plans to use a significant portion of the IPO proceeds for capital expenditure.
According to the issue details, approximately ₹45.15 crore is proposed to be used for purchasing medical equipment for existing and proposed diagnostic centres.
The remaining proceeds are described for general corporate purposes and unidentified inorganic acquisition, as applicable.
Pramodini Medicare IPO Promoters
The promoters of Pramodini Medicare include:
- Dr. Chalasani Kuldeep Kumar
- Dr. Chalasani Kavitha
- Ms. Chalasani Durga Aashritha
- Sri Ram Medicare Private Limited
The promoter and promoter group holding is reported at 85.71% before the IPO, which is expected to reduce to 62.64% after the IPO.
Pramodini Medicare IPO Peer Comparison
The IPO information compares the company with diagnostic sector companies including:
- Invicta Diagnostic Limited
- Krsnaa Diagnostics Limited
- Star Imaging & Path Labs Limited
The comparison includes metrics such as EPS, P/E ratio, RoNW and NAV.
Pramodini Medicare IPO GMP
The Grey Market Premium (GMP) is an unofficial market indicator and can change frequently before the IPO listing. It should not be considered a guaranteed indication of the listing price.
Investors should also note that GMP is not regulated by SEBI and should be considered alongside the company’s financial performance, valuation, business prospects and IPO documents.
Pramodini Medicare IPO Review
Pramodini Medicare’s IPO offers investors exposure to India’s diagnostic healthcare services sector. The company has a diversified portfolio covering radiology, pathology, laboratory diagnostics and nuclear medicine.
The financial numbers show improvement, with revenue rising to ₹63.38 crore and PAT reaching ₹17.38 crore in FY2026. The company also plans to invest IPO proceeds in medical equipment for existing and proposed diagnostic centres, which could help expand its operating capabilities.
At the same time, investors should carefully evaluate the SME IPO structure, minimum investment requirement, valuation, liquidity risk and post-listing volatility before making an investment decision.
Pramodini Medicare IPO – Should You Apply?
The Pramodini Medicare IPO has several points that may attract investors, including strong FY2026 revenue and profit growth, a diagnostic healthcare business model and planned investment in medical equipment.
However, SME IPOs can carry higher liquidity and volatility risks than mainboard IPOs. Investors should therefore study the company’s offer documents and valuation carefully rather than relying only on IPO GMP or expected listing gains.
The IPO appears more suitable for investors who understand the risks associated with SME-listed companies and are evaluating the company from a medium- to long-term perspective.
Pramodini Medicare IPO FAQs
What is Pramodini Medicare IPO?
Pramodini Medicare IPO is an SME IPO through which the company plans to raise approximately ₹69.04 crore. The IPO price band is ₹110 to ₹118 per share and the shares are proposed to be listed on NSE SME.
When will Pramodini Medicare IPO open?
The IPO will open for subscription on August 12, 2026.
When will Pramodini Medicare IPO close?
The IPO will close on August 14, 2026.
What is Pramodini Medicare IPO price band?
The price band has been fixed at ₹110 to ₹118 per equity share.
What is Pramodini Medicare IPO lot size?
The minimum market lot is 2,400 shares, requiring an application of ₹2,83,200 at the upper price band.
What is Pramodini Medicare IPO issue size?
The total issue size is approximately ₹69.04 crore, including a fresh issue of approximately ₹63.14 crore and an offer for sale of up to 5,00,400 shares.
When is Pramodini Medicare IPO allotment?
The basis of allotment is expected on August 17, 2026.
When will Pramodini Medicare IPO list?
The shares are scheduled to list on NSE SME on August 19, 2026.
Disclaimer
This article is for educational and informational purposes only and should not be considered investment advice or a recommendation to buy or sell securities. Investors should read the IPO offer documents carefully and consult a qualified financial adviser before making investment decisions. SME IPO investments can involve higher volatility and liquidity risks.